tanshinone has been researched along with Cardiovascular Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, W; Ma, L; Shao, M; Wang, W; Wang, Y; Yang, Y; Yao, J | 1 |
| Cao, J; Ding, H; Li, H; Xu, Q; Zhang, X | 1 |
| Feng, J; He, Y; Liu, L; Wang, J; Yao, F; Zhou, D | 1 |
| Jiang, C; Liu, J; Tang, H; Wang, B; Wang, D; Zhang, S | 1 |
| Chen, FY; Guo, R; Zhang, BK | 1 |
| Gao, S; Li, H; Little, PJ; Liu, P; Liu, Z; Xu, S | 1 |
| Chan, P; Chen, JJ; Cheng, TH; Hong, HJ; Hsu, FL; Lin, CH; Liu, JC; Tsai, SC | 1 |
| Tian, XH; Wu, JH | 1 |
5 review(s) available for tanshinone and Cardiovascular Diseases
| Article | Year |
|---|---|
A Pharmacological Review of Tanshinones, Naturally Occurring Monomers from
Topics: Abietanes; Anti-Inflammatory Agents; Cardiovascular Diseases; Salvia miltiorrhiza | 2023 |
The protective effect of tanshinone IIa on endothelial cells: a generalist among clinical therapeutics.
Topics: Abietanes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Endothelial Cells; Humans; Inflammation; Oxidative Stress; Salvia miltiorrhiza | 2021 |
[Advances in cardiovascular effects of tanshinone II(A)].
Topics: Abietanes; Animals; Cardiovascular Diseases; Coronary Vessels; Humans | 2015 |
Cardiovascular actions and therapeutic potential of tanshinone IIA.
Topics: Abietanes; Animals; Cardiovascular Agents; Cardiovascular Diseases; Humans; Treatment Outcome | 2012 |
Tanshinone derivatives: a patent review (January 2006 - September 2012).
Topics: Abietanes; Animals; Atherosclerosis; Cardiovascular Diseases; Drug Design; Drugs, Chinese Herbal; Humans; Neoplasms; Neurodegenerative Diseases; Patents as Topic; Prodrugs; Solubility | 2013 |
3 other study(ies) available for tanshinone and Cardiovascular Diseases
| Article | Year |
|---|---|
Tanshinone IIA elevates serum soluble klotho levels and decreases cardiovascular events in patients on maintenance hemodialysis: a prospective before-after study.
Topics: Abietanes; Cardiovascular Diseases; Carotid Intima-Media Thickness; Controlled Before-After Studies; Humans; Prospective Studies; Renal Dialysis | 2020 |
Development of sustained-release pellets to modulate the in vivo processes of the main active components of Danshen: A pharmacokinetic and pharmacodynamic evaluation.
Topics: Abietanes; Benzaldehydes; Benzofurans; Caffeic Acids; Capsules; Cardiovascular Diseases; Catechols; Delayed-Action Preparations; Drugs, Chinese Herbal; Humans; Hydrogen-Ion Concentration; Medicine, Chinese Traditional; Salvia miltiorrhiza | 2019 |
Tanshinone IIA attenuates cyclic strain-induced endothelin-1 expression in human umbilical vein endothelial cells.
Topics: Abietanes; Activating Transcription Factor 3; Cardiovascular Diseases; Cells, Cultured; Cellular Microenvironment; Down-Regulation; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Human Umbilical Vein Endothelial Cells; Humans; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Receptors, Cytoplasmic and Nuclear; RNA Interference; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Soluble Guanylyl Cyclase | 2012 |